Rifampicin 13292-46-1 wiki
Regorafenib | C21H15ClF4N4O3 | CID 11167602 - PubChem
JPM | Free Full-Text | Promoting Precision Cancer Medicine through a Community-Driven Knowledgebase
New Drug Approvals 2012 - Pt. XXI - Regorafenib (Stivarga®)
Regorafenib 755037-03-7 wiki
JPM | Free Full-Text | Promoting Precision Cancer Medicine through a Community-Driven Knowledgebase
Regorafenib | C21H15ClF4N4O3 | CID 11167602 - PubChem
Regorafenib | C21H15ClF4N4O3 | CID 11167602 - PubChem
Trifluridine/tipiracil: A practical guide to its use in the management of refractory metastatic colorectal cancer in Australia - Price - 2020 - Asia-Pacific Journal of Clinical Oncology - Wiley Online Library
File:Regorafenib.svg - Wikipedia
Regorafenib | C21H15ClF4N4O3 | CID 11167602 - PubChem
Regorafenib Impurity 10 2098799-12-1 wiki
Regorafenib | C21H15ClF4N4O3 | CID 11167602 - PubChem
New Drug Approvals 2012 - Pt. XXI - Regorafenib (Stivarga®)
Regorafenib | C21H15ClF4N4O3 | CID 11167602 - PubChem
Deciphera gets Health Canada authorisation for Qinlock to treat GIST
Regorafenib: Uses, Interactions, Mechanism of Action | DrugBank Online
Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma | Future Oncology
Lestaurtinib, JAK2, FLT3 and TrkA receptor tyrosine kinase inhibitor (ab142107) is not available
Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors | Nature Communications
Regorafenib 755037-03-7 wiki
